A new study suggests patients taking semaglutide — the active ingredient in Ozempic and Wegovy — may be at higher risk of an eye condition that can cause blindness. However, study authors and experts told NBC News the findings only show an association, and that additional research is needed to confirm a causal link.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
